PATENT CLAIM ANALYSIS

Application Number: 15889409
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["549", "398000"]

Abstract:
Synthetic cremastranone and cremastranone analogs are disclosed. Additionally, methods for synthesizing cremastranone and cremastranone analogs are disclosed. Methods of treating ocular neovascularization disorders and treating angiogenesis-mediated disease are also disclosed.

Claim (Index 9):
The method as set forth in  claim 8 , wherein SH-11037 (6c) is administered in amounts ranging from about 0.1 \u03bcM to about 100 \u03bcM final intravitreal concentration.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 88.0
- Lexical Diversity: 1.61905
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15523670', '12086792', '13582487', '13946959', '14156314']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7202288046782089
- 35 USC 102 Novelty (BERT): 0.5235724071828955
- Combined Prediction Score: 0.7005631649286775
- Mean Citation Score: 276.669304
- Max Citation Score: 284.84555
- Similarity Product: 183.3661173438549

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test